KRT5/6-positive highly malignant urothelial carcinoma was infiltrated by immune cells at 17.1 ± 1.4% level, whereas in low-grade basal NMIBC, CD8+ cells occupied only 5.1 ± 0.8% of tumor area (p = 0.001). This evidence concerns the gene KRT5 and urothelial carcinoma.